These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11389005)

  • 1. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
    Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
    Reiter A; Schrappe M; Tiemann M; Parwaresch R; Zimmermann M; Yakisan E; Dopfer R; Bucsky P; Mann G; Gadner H
    J Clin Oncol; 1994 May; 12(5):899-908. PubMed ID: 8164040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Reiter A; Schrappe M; Tiemann M; Ludwig WD; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss HJ; Zintl F; Henze G; Riehm H
    Blood; 1999 Nov; 94(10):3294-306. PubMed ID: 10552938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
    Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
    J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of pediatric non-Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA).
    Peña-Hernandez A; Ortiz R; Garrido C; Gomez-Garcia W; Fuentes-Alabi S; Martinez R; Metzger ML; Chantada GL; Ribeiro RC
    Pediatr Blood Cancer; 2019 May; 66(5):e27621. PubMed ID: 30677231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: results based on the NHL BFM 90 protocols.
    Kavan P; Kabickova E; Gajdos P; Koutecky J; Kodet R; McClain KL
    Pediatr Hematol Oncol; 1999; 16(3):201-12. PubMed ID: 10326218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
    Woessmann W; Seidemann K; Mann G; Zimmermann M; Burkhardt B; Oschlies I; Ludwig WD; Klingebiel T; Graf N; Gruhn B; Juergens H; Niggli F; Parwaresch R; Gadner H; Riehm H; Schrappe M; Reiter A;
    Blood; 2005 Feb; 105(3):948-58. PubMed ID: 15486066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood.
    Pillon M; Gregucci F; Lombardi A; Santoro N; Piglione M; Sala A; D'Amore ES; De Santis R; Casale F; Zecca M; Mussolin L; Rosolen A;
    Pediatr Blood Cancer; 2012 Nov; 59(5):828-33. PubMed ID: 22389307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratified Treatment in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study.
    Chen T; Zeng C; Wang J; Sun F; Huang J; Zhu J; Lu S; Liao N; Zhang X; Chen Z; Yuan X; Yang Z; Guo H; Yang L; Wen C; Zhang W; Li Y; Luo X; Wu Z; Yang L; Liu R; Zheng M; He X; Sun X; Zhen Z
    Cancer Res Treat; 2024 Oct; 56(4):1252-1261. PubMed ID: 38810968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
    Neth O; Seidemann K; Jansen P; Mann G; Tiemann M; Ludwig WD; Riehm H; Reiter A
    Med Pediatr Oncol; 2000 Jul; 35(1):20-7. PubMed ID: 10881003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
    Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A
    Klin Padiatr; 1994; 206(4):242-52. PubMed ID: 7967420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome of Chinese children with anaplastic large cell lymphoma by using a modified B-NHL-BFM-90 protocol.
    Sun X; Zhen Z; Lin S; Zhu J; Wang J; Lu S; Chen Y; Zhang F; Sun F; Li P
    Pediatr Hematol Oncol; 2014 Sep; 31(6):518-27. PubMed ID: 25116372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma].
    Sun XF; Liu DG; Zhen ZJ; Chen XQ; Xia Y; Wang ZH; He YJ; Guan ZG
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):581-4. PubMed ID: 16532964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Mottl H; Bajciova V; Nemec J; Al Shemmari S; Al Awadi S
    Pediatr Hematol Oncol; 2003 Mar; 20(2):103-10. PubMed ID: 12554521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
    Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
    Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.